Regeneron Pharmaceuticals
REGN
$824.00
Share price
-0.92%
Change (1 day)
17.01%
Change (1 year)
Categories
EPS for Regeneron Pharmaceuticals (REGN)
EPS in 2023 (TTM): $40.19
According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $40.19. In 2022 the company made an earnings per share (EPS) of $40.52 a decrease over its 2021 EPS that were of $76.45.
EPS history for Regeneron Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $40.19 | -0.81% |
| 2022 | $40.52 | -47% |
| 2021 | $76.45 | 133.36% |
| 2020 | $32.76 | 69.13% |
| 2019 | $19.37 | -14.44% |
| 2018 | $22.64 | 100.71% |
| 2017 | $11.28 | 31.78% |
| 2016 | $8.56 | 38.96% |
| 2015 | $6.16 | 72.55% |
| 2014 | $3.57 | -17.55% |
| 2013 | $4.33 | -44.98% |
| 2012 | $7.87 | -422.54% |
| 2011 | -$2.44 | 92.13% |
| 2010 | -$1.27 | 49.41% |
| 2009 | -$0.85 | -15.84% |
| 2008 | -$1.01 | -36.88% |
| 2007 | -$1.60 | -9.6% |
| 2006 | -$1.77 | 4.12% |
| 2005 | -$1.70 | -323.68% |
| 2004 | $0.76 | -135.51% |
| 2003 | -$2.14 | -24.38% |
| 2002 | -$2.83 | 56.35% |
| 2001 | -$1.81 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.97 | -87.63% | 🇺🇸 USA |
 Novartis NVS | $3.62 | -90.99% | 🇨🇭 Switzerland |
 Amgen AMGN | $14.93 | -62.85% | 🇺🇸 USA |
 Sanofi SNY | $2.93 | -92.70% | 🇫🇷 France |
 Biogen BIIB | $18.46 | -54.07% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$8.61 | -121.42% | 🇺🇸 USA |